Literature DB >> 5294178

Studies on vaccination against bacillary dysentery. 1. Immunization of mice against experimental Shigella infection.

D M Mel, A L Terzin, L Vuksić.   

Abstract

In the course of a series of experiments begun in 1954 a number of different killed vaccines prepared from Shigella flexneri 1 and 2a serotypes were tested for their immunogenicity after intraperitoneal administration in mice followed by challenge with virulent organisms of the same serotype; some live vaccines were also tested intraperitoneally or orally.Maintenance of the mice on Freter's regimen proved a reliable method of rendering them susceptible to intestinal infection with streptomycin-resistant shigellae.Two killed vaccines conferred good protection against intracerebral challenge, but neither live nor killed vaccines administered intraperitoneally protected against oral infection of mice maintained on Freter's regimen. However, oral administration of live vaccine did confer significant protection against homologous oral challenge, the degree of protection depending on the dose of vaccine.

Entities:  

Mesh:

Year:  1965        PMID: 5294178      PMCID: PMC2555250     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  ORAL IMMUNIZATION AND PRODUCTION OF COPROANTIBODY IN HUMAN VOLUNTEERS.

Authors:  R FRETER; E J GANGAROSA
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

2.  [Up to date experiences in the production of an anti-dysentery vaccine. (Preliminary communication)].

Authors:  D MEL
Journal:  Vojnosanit Pregl       Date:  1962-05       Impact factor: 0.168

3.  Studies in immuno-chemistry: The isolation and properties of a specific antigenic substance from B. dysenteriae (Shiga).

Authors:  W T Morgan
Journal:  Biochem J       Date:  1937-11       Impact factor: 3.857

4.  Experimental shigellosis in mice. I. Chronic infection with Shigella dysenteriae type 2.

Authors:  G N COOPER
Journal:  Aust J Exp Biol Med Sci       Date:  1959-06

5.  Experimental enteric Shigella and Vibrio infections in mice and guinea pigs.

Authors:  R FRETER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

  5 in total
  11 in total

Review 1.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

2.  Investigation of oral immunization with streptomycin-dependent Escherichia coli.

Authors:  K Linde; H Koch; H Köditz; M Kittlick; A Stelzner
Journal:  Folia Microbiol (Praha)       Date:  1972       Impact factor: 2.099

3.  Contribution to the study of live streptomycin-dependent Salmonella vaccines: the problem of reversion to a virulent form.

Authors:  I R Vladoianu; F Dubini; A Bolloli
Journal:  J Hyg (Lond)       Date:  1975-10

4.  Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans.

Authors:  K L Kotloff; F R Noriega; T Samandari; M B Sztein; G A Losonsky; J P Nataro; W D Picking; E M Barry; M M Levine
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  Intestinal immunoglobulin A responses in rabbits to a Salmonella typhi strain harboring a Shigella sonnei plasmid.

Authors:  D F Keren; H H Collins; L S Baron; D J Kopecko; S B Formal
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

6.  Oral immunization with polyvalent streptomycin-dependent Escherichia coli vaccine.

Authors:  O Felsenfeld; R H Wolf; W E Greer; R B Brannon
Journal:  Appl Microbiol       Date:  1972-03

7.  Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection.

Authors:  L L van de Verg; C P Mallett; H H Collins; T Larsen; C Hammack; T L Hale
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial.

Authors:  D M Mel; A L Terzin; L Vuksić
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

9.  Studies on vaccination against bacillary dysentery. 2. Safety tests and reactogenicity studies on a live dysentery vaccine intended for use in field trials.

Authors:  D M Mel; R G Papo; A L Terzin; L Vuksić
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

10.  Studies on vaccination against bacillary dysentery. 5. Studies in Erythrocebus patas.

Authors:  D M Mel; B Cvjetanović; O Felsenfeld
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.